What is the dosage of Belbuca?

Belbuca is available in 7 dosages, including 0.075 mg Film, 0.15 mg Film, 0.3 mg Film, 0.45 mg Film, 0.6 mg Film, 0.75 mg Film and 0.9 mg Film

What does Belbuca treat?

Belbuca treats Heroin Dependence and Pain

What is Belbuca made of?

Belbuca contains buprenorphine which is a Partial Opioid Agonist

How is Belbuca administered?

Belbuca is administered as a Buccal

What is Belbuca mechanism of action?

Belbuca mechanism of action is Partial Opioid Agonists

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Belbuca

(buprenorphine)

buprenorphine 0.075 MG Buccal Film [Belbuca]buprenorphine 0.15 MG Buccal Film [Belbuca]

View 5 more

BLACK BOX WARNING

Dosage & administration

* To be prescribed only by health care providers knowledgeable in use of potent opioids for management of chronic pain.
* Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.
* Individualize dosing based on the severity of pain, patient response, prior analgesic experience, and risk factors for addiction, abuse, and misuse.
* Discuss availability of naloxone with the patient and caregiver and assess each patient's need for access to naloxone, both when initiating and renewing treatment with BELBUCA. Consider prescribing naloxone based on the patient's risk factors for overdose.
* For opioid-naïve patients: Initiate therapy with 75 mcg BELBUCA once daily or every 12 hours, as tolerated, for at least 4 days before increasing dose to 150 mcg every 12 hours.
* Conversion from other opioids to BELBUCA: Taper current daily opioid dose to 30 mg oral morphine sulfate equivalents (MSE) or less prior to initiating therapy with BELBUCA.
* For patients taking less than 30 mg oral MSE, initiate therapy with 75 mcg once daily or every 12 hours.
* For patients taking between 30 mg and 89 mg oral MSE, initiate therapy with 150 mcg BELBUCA every 12 hours following analgesic taper.
* For patients taking between 90 mg and 160 mg oral MSE, initiate therapy with 300 mcg BELBUCA every 12 hours following analgesic taper.
* For patients taking greater than 160 mg oral MSE, consider alternate analgesic.

* BELBUCA doses of 600 mcg, 750 mcg, and 900 mcg are only for use following titration from lower doses of BELBUCA.
* Do not abruptly discontinue BELBUCA in a physically-dependent patient because rapid discontinuation of opioid analgesics has resulted in serious withdrawal symptoms, uncontrolled pain, and suicide.
* Patients with Severe Hepatic Impairment: Reduce the starting and incremental dose by half that of patients with normal liver function.
* Patients with Oral Mucositis: Reduce the starting and incremental dose by half that of patients without mucositis.

Belbuca prescribing information

Have more Belbuca questions?

Submit MSL Request

Learn More

Need to report a Belbuca issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Belbuca Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Belbuca Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Belbuca Patient education

Getting started on Belbuca

Instructions For Use - Pain Management

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient toolkit

Patient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Belbuca

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Belbuca

Dosage & administration

Most viewed Belbuca resources

drug label

Belbuca prescribing information

Have more Belbuca questions?

Need to report a Belbuca issue?

prior authorization

Belbuca Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Belbuca Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Belbuca Patient education

Getting started on Belbuca

Patient toolkit

Can't find what you're looking for?